Trupanion, Inc. $TRUP Shares Purchased by Tudor Investment Corp ET AL

Tudor Investment Corp ET AL boosted its holdings in shares of Trupanion, Inc. (NASDAQ:TRUP) by 183.7% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 237,125 shares of the financial services provider’s stock after purchasing an additional 153,530 shares during the quarter. Tudor Investment Corp ET AL’s holdings in Trupanion were worth $10,263,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the business. Millennium Management LLC increased its stake in shares of Trupanion by 185.8% in the third quarter. Millennium Management LLC now owns 619,003 shares of the financial services provider’s stock worth $26,790,000 after buying an additional 402,421 shares during the last quarter. Two Sigma Investments LP grew its holdings in Trupanion by 3,201.0% during the 3rd quarter. Two Sigma Investments LP now owns 224,433 shares of the financial services provider’s stock worth $9,713,000 after acquiring an additional 217,634 shares in the last quarter. Marshall Wace LLP increased its position in shares of Trupanion by 15.5% in the 3rd quarter. Marshall Wace LLP now owns 1,212,151 shares of the financial services provider’s stock worth $52,462,000 after purchasing an additional 163,101 shares during the last quarter. UBS Group AG raised its stake in shares of Trupanion by 183.1% in the 3rd quarter. UBS Group AG now owns 176,289 shares of the financial services provider’s stock valued at $7,630,000 after purchasing an additional 114,021 shares in the last quarter. Finally, Campbell & CO Investment Adviser LLC acquired a new stake in shares of Trupanion in the 3rd quarter valued at about $3,772,000.

Analysts Set New Price Targets

A number of equities analysts recently commented on TRUP shares. Piper Sandler decreased their price target on Trupanion from $60.00 to $45.00 and set an “overweight” rating for the company in a research note on Friday, February 13th. Weiss Ratings cut Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, March 4th. Stifel Nicolaus reduced their target price on Trupanion from $35.00 to $31.00 and set a “hold” rating on the stock in a report on Tuesday, March 31st. Cantor Fitzgerald lowered their price target on Trupanion from $50.00 to $42.00 and set a “neutral” rating for the company in a report on Wednesday, January 14th. Finally, Zacks Research downgraded shares of Trupanion from a “strong-buy” rating to a “hold” rating in a report on Friday, February 13th. Two research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $44.50.

Insider Activity at Trupanion

In related news, CRO Emily Dreyer sold 7,792 shares of the business’s stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $28.15, for a total transaction of $219,344.80. Following the completion of the transaction, the executive owned 35,627 shares in the company, valued at $1,002,900.05. The trade was a 17.95% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO John R. Gallagher sold 5,283 shares of the stock in a transaction on Friday, February 27th. The stock was sold at an average price of $26.52, for a total value of $140,105.16. Following the completion of the sale, the chief operating officer directly owned 32,387 shares in the company, valued at $858,903.24. This represents a 14.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 21,502 shares of company stock worth $580,315 in the last 90 days. 5.42% of the stock is currently owned by company insiders.

Trupanion Price Performance

TRUP opened at $25.65 on Monday. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.27. The company’s 50-day moving average price is $28.18 and its 200 day moving average price is $35.06. Trupanion, Inc. has a fifty-two week low of $24.32 and a fifty-two week high of $57.88. The firm has a market cap of $1.11 billion, a price-to-earnings ratio of 57.00 and a beta of 1.66.

Trupanion (NASDAQ:TRUP) last issued its earnings results on Thursday, February 12th. The financial services provider reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.01). The company had revenue of $376.85 million during the quarter, compared to analyst estimates of $375.89 million. Trupanion had a net margin of 1.35% and a return on equity of 5.39%. The business’s revenue was up 11.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.04 earnings per share. As a group, sell-side analysts expect that Trupanion, Inc. will post 0.13 earnings per share for the current year.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.